Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$177,051,911
+$42,735,954 QoQ
Shares Held
3,693,198
+1.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. NVO ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,051,911 | 3,693,198 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $134,315,957 | 3,654,856 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $235,539,037 | 4,629,305 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $255,871,380 | 4,611,126 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $305,170,962 | 4,421,486 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $318,859,590 | 4,591,872 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $403,356,209 | 4,689,098 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $440,329,908 | 3,698,076 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $520,967,455 | 3,649,765 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $453,214,634 | 3,529,709 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $365,786,474 | 3,535,877 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $326,056,910 | 3,585,407 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $275,781,460 | 1,704,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $273,310,057 | 1,717,419 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $254,136,036 | 1,877,760 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $192,293,569 | 1,930,077 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $218,848,406 | 1,963,999 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $201,659,691 | 1,815,936 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $152,971,168 | 1,365,814 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $114,698,632 | 1,194,653 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $145,711,881 | 1,739,428 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $135,947,507 | 2,016,427 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $149,162,159 | 2,135,464 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $149,001,430 | 2,146,067 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $140,946,549 | 2,152,513 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $134,673,660 | 2,237,104 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||